Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

See remarks

EVP & Chief Legal Officer

President,Surgical

EVP of R&D and CMO

SVP, Controller and CAO

EVP and CFO

CEO and Chair

President, Surgical

Bausch + Lomb Corporation operates as an eye health company worldwide. It operates through three segments: Vision Care, Ophthalmic Pharmaceuticals, and Surgical. The Vision Care segment provides contact lens that covers the spectrum of wearing modalities, including daily disposable and frequently replaced contact lenses; and contact lens care products for therapeutic use, over-the-counter eye drops, eye vitamins, and mineral supplements that address various conditions comprising eye allergies, conjunctivitis, dry eye, and redness relief. The Ophthalmic Pharmaceuticals segment offers proprietary and generic pharmaceutical products for post-operative treatments, as well as for the treatment of eye conditions, such as glaucoma, eye inflammation, ocular hypertension, dry eyes, and retinal diseases. The Surgical segment provides medical device equipment, consumables, and technologies for the treatment of corneal, cataracts, and vitreous and retinal eye conditions; and intraocular lenses and delivery systems, phacoemulsification equipment, and other surgical instruments and devices. Bausch + Lomb Corporation was founded in 1853 and is headquartered in Vaughan, Canada. Bausch + Lomb Corporation is a subsidiary of Bausch Health Companies Inc.

Bausch + Lomb Corporation operates as an eye health company worldwide.

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	See remarks
2024-04-24	Premium	sold (taxes)	Premium	Premium	Premium	EVP & Chief Legal Officer
2024-03-29	Premium	acquired	Premium	Premium	Premium	-
2024-03-29	Premium	acquired	Premium	Premium	Premium	-
2024-03-29	Premium	acquired	Premium	Premium	Premium	-
2024-03-05	Premium	acquired	Premium	Premium	Premium	-
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	President,Surgical
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP of R&D and CMO
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	SVP, Controller and CAO
2024-03-01	Premium	sold (taxes)	Premium	Premium	Premium	EVP and CFO
2024-02-28	Premium	acquired	Premium	Premium	Premium	CEO and Chair
2024-02-28	Premium	acquired	Premium	Premium	Premium	SVP, Controller and CAO
2024-02-28	Premium	acquired	Premium	Premium	Premium	President,Surgical
2024-02-28	Premium	acquired	Premium	Premium	Premium	EVP and CFO
2024-02-28	Premium	acquired	Premium	Premium	Premium	EVP of R&D and CMO
2024-02-28	Premium	acquired	Premium	Premium	Premium	See remarks
2024-02-28	Premium	acquired	Premium	Premium	Premium	EVP & Chief Legal Officer
2023-12-29	Premium	acquired	Premium	Premium	Premium	-
2023-12-29	Premium	acquired	Premium	Premium	Premium	-
2023-12-29	Premium	acquired	Premium	Premium	Premium	-
2023-12-29	Premium	acquired	Premium	Premium	Premium	-
2023-09-29	Premium	acquired	Premium	Premium	Premium	-
2023-09-29	Premium	acquired	Premium	Premium	Premium	-
2023-09-29	Premium	acquired	Premium	Premium	Premium	-
2023-09-29	Premium	acquired	Premium	Premium	Premium	-

BLCO - Bausch + Lomb Corporation Stock Price, Fair Value and News

Latest Insider Trading transactions for BLCO